![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 48, 49571-49574, November 26, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negatively Regulates Basal p65 NF-
B Activity*




**
From the
Institute of Pharmacology, Medical School Hannover, Carl-Neuberg Strasse 1, D-30625, Hannover, Germany, the
Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland, the ¶Department of Chemical Biology, German Research Centre for Biotechnology (GBF), Mascheroder Weg 1, D-38124 Braunschweig, Germany, and ||Cell Signaling Technology, Inc., Beverly, Massachusetts 01915
The activity of NF-
B is controlled at several levels including the phosphorylation of the strongly transactivating p65 (RelA) subunit. However, the overall number of phosphorylation sites, the signaling pathways and protein kinases that target p65 NF-
B and the functional role of these phosphorylations are still being uncovered. Using a combination of peptide arrays with in vitro kinase assays we identify serine 468 as a novel phosphorylation site of p65 NF-
B. Serine 468 lies within a GSK-3
consensus site, and recombinant GSK-3
specifically phosphorylates a GST-p65-(354551) fusion protein at Ser468 in vitro. In intact cells, phosphorylation of endogenous Ser468 of p65 is induced by the PP1/PP2A phosphatase inhibitor calyculin A and this effect is inhibited by the GSK-3
inhibitor LiCl. Reconstitution of p65-deficient cells with a p65 protein where serine 468 was mutated to alanine revealed a negative regulatory role of serine 468 for NF-
B activation. Collectively our results suggest that a GSK-3
-PP1-dependent mechanism regulates phosphorylation of p65 NF-
B at Ser468 in unstimulated cells and thereby controls the basal activity of NF-
B.
Received for publication, September 20, 2004 , and in revised form, September 29, 2004.
* This work was supported by grants from the Deutsche Forschungsgemeinschaft (KR1143/4-1, KR-1143/4-2, and SFB566/B06 (to M. K.) and Schm 1417/3-1, 3-2, 3-3 to (to L. S.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Inst. of Pharmacology, Medical School Hannover, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany. Tel.: 49-511-532-2800; Fax: 49-511-532-4081; E-mail: kracht.michael{at}MH-hannover.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Gong, A. Rifai, Y. Ge, S. Chen, and L. D. Dworkin Hepatocyte Growth Factor Suppresses Proinflammatory NF{kappa}B Activation through GSK3{beta} Inactivation in Renal Tubular Epithelial Cells J. Biol. Chem., March 21, 2008; 283(12): 7401 - 7410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Madhavan, M. Anghelina, D. Sjostrom, A. Dossumbekova, D. C. Guttridge, and S. Agarwal Biomechanical Signals Suppress TAK1 Activation to Inhibit NF-{kappa}B Transcriptional Activation in Fibrochondrocytes J. Immunol., November 1, 2007; 179(9): 6246 - 6254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neumann and M. Naumann Beyond I{kappa}Bs: alternative regulation of NF-{kappa}B activity FASEB J, September 1, 2007; 21(11): 2642 - 2654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ougolkov, N. D. Bone, M. E. Fernandez-Zapico, N. E. Kay, and D. D. Billadeau Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor {kappa}B target genes and induction of apoptosis in chronic lymphocytic leukemia B cells Blood, July 15, 2007; 110(2): 735 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao Transfection with Anti-p65 Intrabody Suppresses Invasion and Angiogenesis in Glioma Cells by Blocking Nuclear Factor-{kappa}B Transcriptional Activity Clin. Cancer Res., April 1, 2007; 13(7): 2178 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Adli and A. S. Baldwin IKK-i/IKK{epsilon} Controls Constitutive, Cancer Cell-associated NF-{kappa}B Activity via Regulation of Ser-536 p65/RelA Phosphorylation J. Biol. Chem., September 15, 2006; 281(37): 26976 - 26984. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, T. Genovese, E. Mazzon, C. Crisafulli, R. Di Paola, C. Muia, M. Collin, E. Esposito, P. Bramanti, and C. Thiemermann Glycogen Synthase Kinase-3beta Inhibition Reduces Secondary Damage in Experimental Spinal Cord Trauma J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 79 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vines, S. Cahoon, I. Goldberg, U. Saxena, and S. Pillarisetti Novel Anti-inflammatory Role for Glycogen Synthase Kinase-3beta in the Inhibition of Tumor Necrosis Factor-{alpha}- and Interleukin-1beta-induced Inflammatory Gene Expression J. Biol. Chem., June 23, 2006; 281(25): 16985 - 16990. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liu and A. B. Malik NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mattioli, H. Geng, A. Sebald, M. Hodel, C. Bucher, M. Kracht, and M. L. Schmitz Inducible Phosphorylation of NF-{kappa}B p65 at Serine 468 by T Cell Costimulation Is Mediated by IKK{epsilon} J. Biol. Chem., March 10, 2006; 281(10): 6175 - 6183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hoberg, A. E. Popko, C. S. Ramsey, and M. W. Mayo I{kappa}B Kinase {alpha}-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 Mol. Cell. Biol., January 15, 2006; 26(2): 457 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hall, I. S. Singh, L. Hester, J. D. Hasday, and T. B. Rogers Inhibitor-{kappa}B kinase-{beta} regulates LPS-induced TNF-{alpha} production in cardiac myocytes through modulation of NF-{kappa}B p65 subunit phosphorylation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2103 - H2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Steinbrecher, W. Wilson III, P. C. Cogswell, and A. S. Baldwin Glycogen Synthase Kinase 3{beta} Functions To Specify Gene-Specific, NF-{kappa}B-Dependent Transcription Mol. Cell. Biol., October 1, 2005; 25(19): 8444 - 8455. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, J. Liu, Y. Yao, M. Baudry, and G. Lynch Deregulation of the Phosphatidylinositol-3 Kinase Signaling Cascade Is Associated with Neurodegeneration in Npc1-/- Mouse Brain Am. J. Pathol., October 1, 2005; 167(4): 1081 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sancho, L. de la Vega, A. Macho, G. Appendino, V. Di Marzo, and E. Munoz Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine J. Immunol., September 15, 2005; 175(6): 3990 - 3999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |